The Claim
The cardiovascular benefit of targeting systolic blood pressure below 120 mm Hg does not extend to individuals with diabetes, prior stroke, or frailty.
What the research says
Challenges is higher
Challenge is ahead, but a single strong supporting study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Lowering systolic blood pressure below 120 mm Hg reduces cardiovascular risk in the general population, but this benefit does not occur in people with diabetes, prior stroke, or frailty.
See the scientific wording
The cardiovascular benefit of targeting systolic blood pressure below 120 mm Hg is not generalizable to individuals with diabetes, prior stroke, or frailty.
In people with diabetes, prior stroke, or frailty, blood vessels are already damaged and cannot repair themselves as well. When blood pressure is pushed very low, the vessels become too stressed and cannot adjust properly, so the heart and brain do not get better protection from damage.
What the research says
3 studiesThe study found that lowering blood pressure below 120 mm Hg helped prevent heart attacks and strokes even in people with diabetes or prior stroke—exactly the opposite of what the claim says. It worked just as well for them as for others.
The study found that even in older, frail diabetic patients, lowering blood pressure below 120 mm Hg still reduced heart attacks and strokes — just like in non-frail patients. So, frailty doesn’t block the benefit, which goes against the claim.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 3 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.